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a b s t r a c t
Translation of foot-and-mouth disease virus RNA initiates at one of two start codons leading to the
synthesis of two forms of leader proteinase Lpro (Labpro and Lbpro). These forms free themselves from the
viral polyprotein by intra- and intermolecular self-processing and subsequently cleave the cellular
eukaryotic initiation factor (eIF) 4G. During infection, Lbpro removes six residues from its own
C-terminus, generating sLbpro. We present the structure of sLbpro bound to the inhibitor E64-R-P-NH2,
illustrating how sLbpro can cleave between Lys/Gly and Gly/Arg pairs. In intermolecular cleavage on
polyprotein substrates, Lbpro was unaffected by P1 or P10 substitutions and processed a substrate
containing nine eIF4GI cleavage site residues whereas sLbpro failed to cleave the eIF4GI containing
substrate and cleaved appreciably more slowly on mutated substrates. Introduction of 70 eIF4GI residues
bearing the Lbpro binding site restored cleavage. These data imply that Lbpro and sLbpro may have
different functions in infected cells.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
Introduction
Virally encoded proteinases play essential roles not only in the
processing of the viral proteins but also in cleavage of host cell
proteins in order to manipulate cellular processes to the advantage
of the virus. One of the ﬁrst such reactions to be documented was
the modiﬁcation of cellular translation factors during picornaviral
replication leading to the shut-off of protein synthesis from capped
cellular mRNA (Etchison et al., 1982; Leibowitz and Penman, 1971).
This reaction was subsequently shown to be performed by the 2A
proteinase (2Apro) in enteroviruses (Kräusslich et al., 1987), a
chymotrypsin-like cysteine proteinase (Petersen et al., 1999),
whereas in aphthoviruses, the proteolysis is performed by the
leader proteinase (Lpro, illustrated in Fig. 1) (Devaney et al., 1988),
a papain-like cysteine proteinase (Guarné et al., 1998). The targets
of both proteinases are the two homologues of the host protein
eukaryotic initiation factor (eIF) 4G (Gingras et al., 1999). Cleavage
of the eIF4G homologues prevents recruitment of capped mRNAs to
the ribosome (Lamphear et al., 1995) whereas viral RNA can still be
translated under these conditions as it initiates via an internal
ribosome entry segment (IRES) (Martinez-Salas and Ryan, 2010). In
addition, Lpro has been shown to be involved in impairing the host
innate immune defence by inﬂuencing NF-κB activation and to have
deubiquitinase activity (de Los Santos et al., 2007, 2009; Skern and
Steinberger, 2014).
Given these involvements in such different reactions as intra-
molecular and intermolecular self-processing, eIF4G cleavage and
deubiquitination, it is not surprising that Lpro has unusual speci-
ﬁcity determinants. These are well illustrated by the sequences of
the three Lpro cleavage sites that have been determined directly by
protein sequencing: KVQRKLKnGAGQSS for both intra- and inter-
molecular cleavage on the viral polyprotein between the C-terminus
of Lpro and VP4 (Strebel and Beck, 1986), PSFANLGnRTTLST on eIF4GI
(Kirchweger et al., 1994) and VPLLNVGnSRRSQP on eIF4GII (Gradi et
al., 2004). Studies on Lpro intramolecular self-processing and cleavage
of peptide substrates have revealed that Lpro can cleave before or
after basic residues provided that the other amino acid before or
after the scissile bond is glycine (Glaser et al., 2001; Nogueira Santos
et al., 2012; Santos et al., 2009). However, a peptide that contained
basic residues before and after the scissile bond was refractory to
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cleavage and was subsequently shown to be an inhibitor in the
micromolar range (Santos et al., 2009). This information was then
used to develop a nanomolar epoxide inhibitor based on E64, termed
E64-R-P-NH2 (Santos et al., 2009); the structure and inhibitor
parameters are shown in Fig. 2, together with those of the other
inhibitors used or referred to in this work. The slow formation of the
tight enzyme–inhibitor complex indicates that inhibition follows
slow-binding kinetics (Santos et al., 2009; Zhou et al., 1998).
The structural basis for this unusual speciﬁcity has not been
elucidated, as the present structures determined by X-ray crystal-
lography and NMR (Cencic et al., 2007; Guarné et al., 1998, 2000;
Steinberger et al., 2013) only provide information on the S binding
region but not on the S0 binding region of Lpro. The nomenclature for
sites (S) on the enzyme binding to residues of substrate (P) is that of
Schechter and Berger (1967); prime site residues are those C-terminal
to the scissile bond. Indeed, information on the nature of the S0 region
from related papain-like proteinases is also sparse (Turk et al., 2012),
with structural information only being available for cathepsin B (Stern
et al., 2004; Turk et al., 1995; Yamamoto et al., 1997) determined with
inhibitors similar to E64-R-P-NH2 (Fig. 2). However, cathepsin B is also
unusual in being an exopeptidase, with an occluding loop that
prevents access beyond the S20 site, that is the site on the enzyme
interacting with the P20 residue of the substrate (Stern et al., 2004).
Thus, any information on the S0 binding region of FMDV Lpro will shed
light on the nature of this region in papain-like cysteine proteinases
generally.
Understanding of the mechanism of Lpro is complicated by the
presence of different forms of the protein in the infected cell (Sangar et
al., 1987, 1988). Two isoforms, Labpro and Lbpro (Fig. 1), arise from the
presence of two in-frame AUG codons for the initiation of protein
synthesis on the viral RNA (Sangar et al., 1987). Consequently, the
Labpro possesses an additional 28 amino acids at the N-terminus than
Lbpro. Cao et al. (1995) demonstrated in cell culture that Lbpro was
essential whereas Labpro was not; nevertheless, there may still be as
yet unknown roles for Labpro during infection in the host organism. In
addition, a shortened form of Lbpro (sLbpro) lacking 6 or 7 amino acids
at the C-terminus has long been known (Sangar et al., 1988). The
truncation arises through Lbpro self-cleavage (Sangar et al., 1988) and
Fig. 1. Schematic drawing of FMDV Lpro self-processing and eIF4G cleavage. (A) The FMDV RNA genome is shown as a black line, the single open reading frame as a box with
the names of the mature proteins and the position of the IRES. Lpro, being expressed either as Labpro or Lbpro, is indicated in red. (B) Synthesis of the polyprotein from the
FMDV genome showing that Lbpro can either be freed by an intramolecular or intermolecular reaction. sLbpro (shown in orange) is generated by self-processing at the
C-terminus of Lbpro. (C) The effect of eIF4G cleavage by Lbpro or sLbpro. The cellular mRNA is shown as a black line with the cap structure as a ﬁlled circle. Lbpro and sLbpro are
shown in red and orange, respectively. The 40S ribosomal subunit, the polyA-binding protein (PABP), eIF4G, eIF4E, eIF4A and eIF3 are shown in different shades of grey.
Following cleavage of eIF4G by Lbpro or sLbpro, the capped mRNA is no longer connected to the 40S subunit and cannot be translated. In contrast, the viral RNA can bind to the
C-terminal fragment of eIF4G and thus to the 40S subunit via eIF3.
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can be observed in vitro when Lbpro expressed in rabbit reticulocyte
lysates (RRLs) is incubated for longer time periods (e.g. 1 h)(Mayer et
al., 2008). A separate function for sLbpro has not been identiﬁed;
however, one report suggested that Lbpro and sLbpro may differ in their
cleavage efﬁciencies in intermolecular cleavage of the polyprotein
substrate (Cencic et al., 2007).
One clear difference between Lbpro and sLbpro is the ability of Lbpro
to form homodimers through interactions of the C-terminal extension
(CTE) of one monomer and the substrate binding site of the neighbour-
ing one and vice versa. sLbpro cannot form homodimers in this way
because it lacks the six most C-terminal residues. The Lbpro homodimer
has been observed by X-ray crystallography and NMR (Cencic et al.,
2007; Guarné et al., 1998, 2000; Steinberger et al., 2013) with the KD
being estimated from NMR analyses to be in the millimolar range
(Cencic et al., 2007). Therefore, formation of the homodimer at
concentrations of Lbpro achieved when it is synthesised in the infected
cell seems unlikely unless there is a high local concentration. In
contrast, both Lbpro and sLbpro use an exosite featuring residues
Tyr183 to Leu188 as well as Cys 133 to recognise binding sites located
on the eIF4G homologues, located in both cases 20 to 30 amino acids
from the cleavage site (Foeger et al., 2005). How this binding favours
Lbpro or sLbpro cleavage of the eIF4G homologues is not known.
To investigate further the properties of sLbpro, we set out to
determine the structure of sLbpro complexed with the inhibitor
E64-R-P-NH2 and to deﬁne differences in the cleavage of inter-
molecular polyprotein substrates by sLbpro and Lbpro.
Materials and methods
Materials
The bacterial expression plasmid pET-11d sLbpro (FMDV resi-
dues 29–195) was created by site-directed PCR mutagenesis of
pET-11d sLbpro C51A, described earlier (Guarné et al., 1998;
Kirchweger et al., 1994), to restore the catalytic cysteine.
The plasmids that were used as templates for in vitro tran-
scription pCITE-1d Lbpro (residues 29–201 of Lbpro), pCITE-1d
sLbpro (residues 29–195 of Lbpro) and pCITE-1d Lbpro C51A VP4/
VP2 (residues 29–201 of Lbpro, all 85 residues of VP4 and 78
residues of VP2) have been described (Glaser et al., 2001). The
constructs pCITE-1d Lbpro C51A VP4/VP2 containing the mutations
at position P1 and P10 of the Lbpro-VP4 cleavage site
(VQRKLGnRAGQ, VQRKLKnRAGQ, VQRKLGnAAGQ) were created
by site-directed PCR mutagenesis of pCITE-1d Lbpro C51A VP4/
VP2. The construct pCITE-1d Lbpro C51A VP4/VP2 containing the
eIF4GI sequence SFANLGnRTTL at the Lbpro-VP4 cleavage site,
termed pCITE-1d Lbpro C51A VP4/VP2 SFANLGnRTTL (FMDV resi-
dues 29–195 of Lbpro, residues 669–678 of eIF4GI, residue 5–85 of
VP4 and 78 residues of VP2), has been described (Cencic et al.,
2007). The construct pCITE-1d Lbpro C51A VP4/VP2 containing
residues 599–678 of eIF4GI, termed pCITE-1d Lbpro C51A eIF4GI599-
668 VP4/VP2 SFANLGnRTTL, (FMDV residues 29–195 of Lbpro,
residues 599–678 of eIF4GI, residue 5–85 of VP4 and 78 residues
of VP2) was created by PCR ampliﬁcation of residues 599–678 of
eIF4GI using the plasmid pKS eIF4GI 400–739 as template and
cloning of this fragment into pCITE-1d Lbpro C51A VP4/VP2 via the
restriction sites Bpu10I and SacI.
The inhibitor E64-R-P-NH2 was prepared as described (Nogueira
Santos et al., 2012).
Protein expression and puriﬁcation
Protein expression and puriﬁcation were performed as
described by Steinberger et al. (2013) with the following modiﬁca-
tions. Proteins were expressed from the construct pET-11d sLbpro
transformed into BL21(DE3)LysE bacteria. To avoid degradation of
Fig. 2. Chemical structures of inhibitors referred to in this work. The structures and kinetic parameters of the inhibitor E64-R-P-NH2 (Nogueira Santos et al., 2012)
crystallised with sLbpro are shown together with those of the inhibitors NS-134 (Stern et al., 2004) and CA074 (Yamamoto et al., 1997) whose structures were determined in
complex with cathepsin B. The correspondence of side-chains in the inhibitors to substrate side-chains is shown using the nomenclature of Schechter and Berger, (19670.
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the active protease, all puriﬁcation steps were carried at a max-
imum of 10 1C.
Preparation of the sLbpro-E64-R-P-NH2 complex
Puriﬁed sLbpro was incubated with a ﬁvefold molar excess of
E64-R-P-NH2 over night at 4 1C to allow complex formation.
Subsequently, the complex was dialysed against a buffer contain-
ing 50 mM NaCl, 10 mM Tris HCl pH 8, 1 mM TCEP, 5% glycerol to
remove excess inhibitor. The concentration was adjusted to 18 mg/
ml and centrifuged at 18,000g for 10 min at 4 1C to remove
precipitated protein.
Crystallisation, data collection, structure determination and
reﬁnement
Crystals of the sLbpro-E64-R-P-NH2 complex were initially
obtained in the Wizard I and II screen crystallisation screen
(Emerald Bio), using the sitting-drop vapour diffusion technique
and a nanodrop-dispensing robot (Phoenix RE; Rigaku Europe,
Kent, United Kingdom), and optimised to 0.1 M sodium acetate pH
4.8, 0.9 M NaH2PO4 and 1.2 M K2HPO4 using the hanging drop
vapour diffusion technique at 22 1C and seeding technique. The
seed stock was produced by a “seed-bead” kit from Hampton
Research (Luft and DeTitta, 1999). The crystals were ﬂash-frozen in
liquid nitrogen in a reservoir solution supplemented with 25%
glycerol prior to data collection.
Diffraction data sets were collected at the ESRF Synchrotron
(Grenoble) at beamline ID14-1 at 100 K using a wavelength of
0.93 Å to 1.6 Å resolution, processed using the XDS package
(Kabsch, 2010), converted to mtz format using POINTLESS and
scaled with SCALA (Winn et al., 2011).
The crystal structure was solved by difference Fourier techni-
ques using the protein atomic coordinates of the inactive mutant
of sLbpro from the Protein Data Bank (accession code 1QMY).
Model building and reﬁnement steps were performed with
REFMAC and COOT. The structure was reﬁned using the programs
REFMAC (Murshudov et al., 1997) and Phenix Reﬁne (Adams et al.,
2010) and model building was done with the program Coot
(Emsley and Cowtan, 2004). Data collection and reﬁnement
statistics are shown in Table 1. Stereo-chemistry and structure
quality were checked using the MolProbity web server (Davis
et al., 2007).
In vitro transcription and translation
In vitro transcription reactions were performed as described
(Neubauer et al., 2013) with the following modiﬁcations. The
plasmids were cleaved with BamHI for the expression of active
proteinases (pCITE-1d Lbpro and pCITE-1d sLbpro) and SalI for the
substrates (pCITE-1d Lbpro C51A VP4/VP2 and derivatives thereof).
In vitro translation reactions were performed as described
(Cencic et al., 2007) with the following modiﬁcation. To translate
substrate proteins and proteinases, RNA was added to the reaction
at concentrations of 14 ng/ml.
Electrophoresis and immunoblotting
Electrophoresis and immunoblotting for protein analysis were
performed as described (Neubauer et al., 2013), except for the
separation of translation products when SDS-PAGE gels containing
17.5% acrylamide were used (Dasso and Jackson, 1989).
Structural comparisons
Structural alignments and superimpositions were done using
Coot (Emsley and Cowtan, 2004; Krissinel and Henrick, 2004). All
drawings were created using PyMOL (DeLano, 2002). The electro-
static potential of sLbpro was calculated using the Adaptive
Poisson-Boltzmann Solver package (Baker et al., 2001) within
PyMOL.
Accession numbers
Coordinates for the structure determined here have been
deposited in the protein data bank (pdb accession code 4QBB).
The PDB identiﬁers of the structures used for comparisons were
1QOL for Lbpro, 1GEC for glycyl endopeptidase-complex with
benzyloxycarbonyl-leucine-valine-glycine-methylene, 3CH3 for
SERA5 from plasmodium falciparum, 1SP4 for bovine cathepsin
B-complex with NS-134, 1QDQ for bovine cathepsin B-complex
with CA074.
Results and discussion
The crystal structure of the inhibitor E64-R-P-NH2 bound to
sLbpro has been determined. The correspondence of the side-
chains in the inhibitor to substrate side-chains is illustrated in
Fig. 2; a portion of the electron density in the ﬁnal model of the
inhibitor bound to the active site is shown in Fig. 3. Three chains,
termed A, B and C were found in the asymmetric unit of the crystal
lattice. Electron density was visible for sLbpro residues 29–187 of
chain A, 29 to 184 of chain B and 29–185 of chain C. For the
inhibitor, electron density was visible for all atoms except for those
Table 1
X-ray parameters and reﬁnement statistics.
Data collection
Source ID14-1, ESRF
Wavelength (Å) 0.93
Resolution (Å) 45.35–1.6 (1.69–1.6)a
Space group P21
Unit cell (Å, 1)
a¼45.81 b¼110.68, c¼56.77
α¼γ¼90, β¼98.12
Molecules / a.u. 3
Unique reﬂections 72906 (10232)
Completeness (%) 99.0 (95.0)
Rmerge
b 0.037 (0.174)
Rmeas
c 0.041 (0.213)
Multiplicity 4.9 (2.9)
I/sig(I) 29.9 (5.6)
BWilson (Å2) 22.5
Reﬁnement
Rcryst
d/ Rfreee 16.9/20.1
R.m.s.d. bonds (Å) 0.011
R.m.s.d. angles (1) 1.4
Ramachandran plot (%)
favored/allowed/outliers 96.9/3.1/0
a Values in parentheses are for the highest resolution shell.
b Rmerge ¼
∑hkl∑Ni ¼ 1jIiðhklÞ  IðhklÞj
∑hkl∑Ni ¼ 1IiðhklÞ
c Rmeas ¼
∑hkl
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
N=ðN1Þ
p
∑Ni ¼ 1jIiðhklÞ  I ðhklÞj
∑hkl∑Ni ¼ 1IiðhklÞ
where IðhklÞ is the mean intensity of
multiple IiðhklÞ observations of the symmetry-related reﬂections, N is the redun-
dancy
d Rcryst ¼
∑ Fobs
  Fcalc
  
∑ Fobs
 
e Rfree is the cross-validation Rfactor computed for the test set of reﬂections (5%)
which are omitted in the reﬁnement process.
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of the P3 amino-alkyl guanidinium group (referred to as Arg-m in
the text and ﬁgures) and P10 Arg. For P3 Arg-m, density was visible
up to the Cβ atom for chain A, for all atoms of chain B (due to
favourable interactions with an Asp residue from a symmetry
related molecule) and to atom Nε for chain C. For the P10 arginine
residues, density up to the Cβ atom for chain A was visible whereas
for chains B and C density was observed to the Cγ atom. The
remaining atoms of these side-chains including the guanidinium
group were modelled in Figs. 4 to 7 after the side-chain trace of
Cα to Cγ in the most likely conformation. Density for the covalent
bond between the active site cysteine and the inhibitor (atom C1)
was very clear in all three chains. Superimposition of the structure
of sLbpro bound to E64-R-P-NH2 with the unbound Lbpro structure
of sLbpro C51A C133S (PDB ID 1QMY, chainB) (Guarné et al., 2000)
gave an r.m.s.d. of 0.35 Å over 156Cα atoms superimposed. Given
that the best resolution of the inhibitor was found in chain B, all
structural analysis is based on this chain.
To determine the binding of E64-R-P-NH2 to sLbpro, we ﬁrst
compared its arrangement in the substrate binding site of sLbpro to
that of the last three residues of the CTE observed in the crystal
structure of Lbpro (Guarné et al., 1998). Fig. 4 shows that the
positions of the P3 Arg-m side-chain of the inhibitor and the P3
Lys side-chain of the CTE occupy similar positions in the two
structures. The Cγ atom of the P10 Arg residue of the inhibitor lies
between the side-chains of Asp49 (distance from Cγ to carboxy
group of Asp49 is 4.2 Å) and Glu147 (distance from Cγ to Cβ of
Glu147 is 4.5 Å). Given the uncertainty in the position of the
guanidinium group (as mentioned earlier, the remaining atoms
were modelled as no density was observed), a closer localisation is
not possible. Nevertheless, the superimposition in Fig. 4B shows
that the P1 Lys of the CTE lies almost equidistant between Asp49,
Glu96 and Glu147. The disorder of the P10 Arg in the structure of
the inhibitor presented here indicates that the side-chain is
ﬂexible; in contrast, in the previously published structure of Lbpro
C51A, good density was observed to the P1 Lys residue in the
substrate binding site of Lbpro (Guarné et al., 1998). Given that the
polypeptide chain is fully extended in both the CTE and E64-R-P-
NH2 bound structures, this explains how a peptide containing Lys
and Arg at P1 and P10 can be refractory to cleavage (Nogueira
Santos et al., 2012). If the Lys at P1 points away from the globular
domain, an Arg side-chain at P10 would have to point towards it.
Thus, on oligopeptide substrates at least, the enzyme can only
Fig. 3. Stereo view of the arrangement of the inhibitor E64-R-P-NH2 and the substrate binding site of sLbpro. 2F0–Fc maps contoured at 1 σ are shown as grey mesh for the
inhibitor and the sLbpro residues Asp49, Cys51, Glu96 and Glu147. The inhibitor is shown as green sticks. Residues of sLbpro interfacing with the inhibitor are shown as grey
sticks. Oxygen, nitrogen and sulphur atoms are coloured red, blue and yellow, respectively. Due to the lack of electron density, no structure is shown for the P1‘ Arg residue of
E64-R-P-NH2 from the Cδ atom onwards.
Fig. 4. Comparison of the binding of E64-R-P-NH2 and P1-P3 of the CTE. (A) The inhibitor (green sticks) is shown in the substrate binding site of sLbpro. Side-chains of the
inhibitor are labelled. In Figs. 4 to 7, the atoms of the P10 Arg residue from Cδ onwards are modelled based on the most favourable conformation. Residues of the active site
(Cys51, His148, Asp163) as well as the three acidic residues discussed in the text are shown as sticks. (B) As in A, with the P1-P3 residues (in yellow and labelled) of the CTE
superimposed for comparison.
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accommodate a basic residue at one of the positions, presumably
because it requires a glycine with its greater freedom of rotation at
the other. However, the data do not answer the question why a
peptide containing Lys and Arg at P1 and P10 can inhibit Lbpro
(Nogueira Santos et al., 2012). This implies that the inhibitor may
bind in a mode that has not yet been observed that moves the
scissile bond out of the active site. However, additional structural
information will be required to elucidate the nature of the binding
of this peptide.
Overall, comparison of the binding of the E64-R-P-NH2 and the
CTE residues (Fig. 5) show that the P1/P10 binding area is a deep
cleft surrounded by the acidic residues Asp49, Glu96 and Glu147.
We set out to determine whether other papain-like cysteine
proteinases have been identiﬁed that have a similar arrangement
of three acidic residues in the vicinity of the S1/S10 binding sites.
Berti and Storer (Berti and Storer, 1995) compared the sequences
of 48 representative papain-like cysteine proteinases. Only one,
SERA5 (Serine repeat antigen 5, termed PfalI in (Berti and Storer,
1995)) from P. falciparum showed acidic amino acids at the
equivalent positions to those in sLbpro; these are Asp594, Glu638
and Asp761 which are equivalent to Asp49, Glu96 and Glu147 of
sLbpro ((Hodder et al., 2009); Fig. 6A and B). However, little is
known about the biochemistry of this protein; indeed, proteolytic
activity has not been shown. Furthermore, the putative active site
residue is serine, not cysteine. In addition, the authors suggested
that Asp594 (equivalent to Asp49) of SERA5 is too near to the
substrate binding site to allow substrate to bind.
A second enzyme, glycyl endopeptidase (ppiv in Berti and
Storer, (1995)), also possesses two acidic residues, Glu23 and
Asp158, equivalent to Asp49 and Glu147. The third residue
(Asn64, equivalent to Glu96 in sLbpro) is however not acidic and
is followed by Arg65. As can be seen in Fig. 6C, the presence of
Glu23 and Arg65 preclude the entry of any substrates with amino
acids larger than glycine at P1, thus conferring the speciﬁcity
referred to in the name glycyl endopeptidase.
It should be noted that only these three papain-like enzymes
have an amino acid other than glycine at the position equivalent to
Gly23 in papain (equivalent to Asp 49 in sLbpro). Superimposition
of the three structures (Fig. 6D) shows that Asp49 in sLbpro is
further away from the substrate binding site than Glu23 or Asp594
in glycyl endopeptidase (O’Hara et al., 1995) and SERA5 (Hodder
et al., 2009). This is due to the presence of only four residues in
sLbpro lying between the oxyanion hole deﬁning residue (Asn46)
and the active site Cys51. In all other papain-like cysteine protei-
nases, ﬁve residues are present between the oxyanion-hole resi-
due Gln19 and the active site nucleophile Cys25. Interestingly,
Glu23 of glycyl endopeptidase is closer to the substrate binding
site than Asp594 in SERA5, suggesting that the substrate binding
Fig. 5. Electrostatic interactions involved in sLbpro interaction with E64-R-P-NH2 and the P1-P3 residues of the CTE. The electrostatic potential of sLbpro was calculated using
the Adaptive Poisson–Boltzmann Solver package (Baker et al., 2001) within PyMOL (DeLano, 2002). The surface is coloured according to the electrostatic potential ranging
from 5 (red) to þ5 (blue) kT/e. (A) The inhibitor E64-R-P-NH2 is shown as green sticks, (B) residues P1-P3 of the CTE as yellow sticks. The representations on the right are
rotated 901 on the x-axis relative to those on the left.
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Fig. 6. Comparison of arrangement of negatively charged residues in the substrate binding sites of sLbpro, glycyl endopeptidase and SERA5. (A) sLbpro bound to E64-R-P-NH2
(green sticks). (B) Substrate binding site of SERA5. (C) Glycyl endopeptidase bound to the inhibitor benzyloxycarbonyl-leucine-valine-glycine-methylene (yellow sticks).
(D) Stereo view of the superimposition of the three structures in A–C. Residues referred to in the text are shown as sticks.
Fig. 7. Comparison of the S10 and S20 binding sites of FMDV sLbpro and cathepsin B. (A and B) E64-R-P-NH2 (green sticks) bound in the substrate binding site of Lbpro with the
inhibitors NS-134 (A, blue sticks) and CA074 (B, magenta sticks) superimposed. (C and D) NS-134 (C) and CA074 (D) bound to the substrate binding site of cathepsin B with E64-R-P-
NH2 superimposed. The colour coding is as in A and B. The structure of Trp221 for which there is no equivalent in Lbpro is shown as sticks as are residues referred to in the text.
J. Steinberger et al. / Virology 468-470 (2014) 397–408 403
site of SERA5 may be more open than previously thought. In
contrast, Glu96 does not superimpose well with Glu638, with the
Cα lying 3.7 Å apart (Fig. 6D). Finally, as an important control for
the accuracy of the structural superimposition, we note that the Cα
of the catalytic histidines (H148, H762 and H159) superimpose
well (Fig. 6D).
Comparisons with inhibitor complexes from cathepsin B
Information on the structural details of the S10 and S20 binding
sites in papain-like cysteine proteinases is limited, especially for
the S20 site (Turk et al., 1998, 2012). Indeed, structures of
compounds with residues bound in the S20 position are only
available for cathepsin B complexed with the inhibitors CA030,
CA074 and NS-134 (Fig. 2; (Stern et al., 2004; Turk et al., 1995;
Yamamoto et al., 1997)). To compare the binding of the inhibitors
CA074 and NS-134 to cathepsin B (CA030 differs only in the length
and chemical bond of the N-terminal aliphatic moiety (Turk et al.,
1995)) and that of E64-R-P-NH2 to sLbpro, the structures of
cathepsin B complexes with CA074 and NS-134 were superim-
posed on that of sLbpro using the SSM tool of Coot (Krissinel and
Henrick, 2004). The r.m.s.d. values were 2.44 Å for sLbpro super-
imposed on cathepsin B complexed to CA074 (1QDQ) and 2.31 Å
for sLbpro superimposed on cathepsin B complexed to NS-134
(1SP4). Fig. 7A and B show the positions of the inhibitors NS-134
and CA-074 relative to E64-R-P-NH2 on sLbpro; Fig. 7C and D show
the relationships on the structure of cathepsin B.
The P10 residues of CA074 and NS-134 are Ile and Leu,
respectively, in contrast to the Arg found in E64-R-P-NH2. Despite
the difference in chemical composition, however, the side-chains
of these residues superimpose well and occupy the same relative
space. The speciﬁcity of cathepsin B for these large hydrophobic
residues is derived from the presence of a hydrophobic pocket
made up of residues Phe174, Val176, Phe180, Leu181, M196 and
Trp221 (Figs. 7C and D). In contrast, in sLbpro, there is no
equivalent loop to those in cathepsin B bearing residues Phe174
to Leu181 and Met196 or Trp221. This region is thus open and, as
mentioned before, the presence of Glu147 and Asp49 enable sLbpro
to accept well the arginine residue.
At the P20 position, all three inhibitors have a proline residue. It
is clear that the positions of the proline residues from CA074 and
NS-134 on the one hand and sLbpro on the other are different. In
sLbpro, the proline P20 residue of E64-R-P-NH2 lies closer to
Asp163, the third member of the catalytic triad. Two factors
appear to be responsible for this. The ﬁrst is the absence of a
residue equivalent to Trp221 in cathepsin B (Trp177 in papain) that
pushes the proline residue away from Asn219 (equivalent to
Asp163 in sLbpro). Second, albeit only in chain A, the sLbpro residue
Asp164 forms a hydrogen bond (2.7 Å) to the terminal nitrogen on
the proline residue whereas in cathepsin B, the terminal carboxyl
group of the proline is co-ordinated by His110 and His111 in the
occluding loop, a structure unique to cathepsin B that is respon-
sible for its exopeptidase activity. It is clear from the structure that
there is no binding pocket for the P20 residue in sLbpro.
Lbpro and sLbpro differ in cleavage efﬁciencies on intramolecular
substrates
The structural analysis illustrates how sLbpro can bind to an
inhibitor bearing Leu, Gly and Arg at the P2, P1 and P10 sites,
respectively, the very residues found at the eIF4GII cleavage site.
Nevertheless, a peptide corresponding to the eIF4GI peptide
(SFANLGnRTTL) was a poor substrate for both Lbpro and sLbpro
((Santos et al., 2009); unpublished data). However, the eIF4GI
cleavage site when introduced into the background of the poly-
protein substrate was efﬁciently cleaved by Lbpro but was still
Fig. 8. Effects of P1 or P10 site mutations on the intermolecular cleavage efﬁciency of Lbpro. Intermolecular processing of the precursor Lbpro C51A VP4/VP2 (A) and variants
thereof (B–E) by Lbpro. The cleavage sequence present in the background of the polyprotein is shown in grey boxes. Differences from the wild-type sequence of the precursor
are underlined. RRLs were programmed with RNA (14 ng/ml) coding for the polyprotein Lbpro C51A VP4/VP2. Translation was performed for 20 min at 30 1C in the presence of
[35S]-Met and terminated by the addition of unlabelled Met for 10 min. RNA (14 ng/ml) coding for Lbpro was added and translation was continued at 30 1C. The reaction was
terminated by placing the samples on ice and the addition of Laemmli sample buffer containing excess unlabelled Met and Cys. 10 ml aliquots were analysed by 17.5% SDS-
PAGE gels, followed by ﬂuorography. Uncleaved precursor Lbpro C51A VP4/VP2 and cleavage products Lbpro C51A and VP4/VP2 are indicated. The asterisk (*) indicates an
aberrant cleavage product. Negative controls devoid of any RNA (-sub, -prot) or comprising only RNA encoding the precursor (þsub, -prot) are shown on the right of each gel.
Protein standards are shown on the left. Each cleavage reaction was performed twice; a representative autoradiogram for each is shown.
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refractory to cleavage by sLbpro (Cencic et al., 2007). Examination
of the state of the endogenous eIF4GI in RRLs used for the
experiments showed that it was cleaved by both Lbpro and sLbpro
(Cencic et al., 2007).
To understand these observations and illuminate differences in
cleavage efﬁciencies between Lbpro and sLbpro, we decided to
investigate further the cleavage of intermolecular polyprotein
substrates using the system described by Cencic et al. (2007).
Here, a fragment of the FMDV polyprotein encoding an inactive
form of Lbpro, VP4 and part of VP2 (termed Lbpro C51A VP4/VP2) is
labelled with 35S methionine by translation in RRLs (Cencic et al.,
2007). Subsequently, cold methionine is added and an mRNA
encoding an active, mature Lbpro or sLbpro is added. The enzyme
was synthesised from an RNA molecule rather than adding
puriﬁed recombinant proteinase for two reasons. First, prepara-
tions of puriﬁed active Lbpro always contain some sLbpro that arises
from self-processing, even when all puriﬁcation steps are done at
4 1C (Kirchweger et al., 1994). Second, the translation of the RNA
followed by Lbpro cleavage of the eIF4G isoforms in the RRLs
resembles more closely the in vivo situation during an FMDV
infection. The labelled substrate and products are separated by
SDS-PAGE and detected by ﬂuorography. Although it is very
difﬁcult to vary either the enzyme or substrate concentrations in
this assay, it still provides qualitative information on differences in
the rates of reaction between different forms of Lpro.
A typical experiment is shown in Fig. 8A, with Lbpro cleaving
the wild-type sequence between 15 and 30 min. The Lbpro moiety
has four methionine residues compared to only two in the
VP4/VP2 part, providing a partial explanation for the lower
intensity of the latter band (Glaser et al., 2001). In addition, we
have evidence that the VP4/VP2 part is degraded in the RRLs (data
not shown), with degradation being enhanced when a residue
other than the wild-type glycine is present at the N-terminus of VP4
(see Fig. 8B–E). We ﬁrst investigated the effect of substituting
residues at the P1 and P10 positions with residues (underlined in
Fig. 8B–D), several of which had been shown to be detrimental to
peptide cleavage (Guarné et al., 2000; Nogueira Santos et al., 2012;
Santos et al., 2009). However, none of the modiﬁcations affected the
cleavage efﬁciency of Lbpro (Table 2). These results show that there
are clear differences between the activity of Lbpro on peptides and
polyprotein substrates, indicating that the conformation of the
substrate may be different in the background of the polyprotein. In
addition, as previously observed, replacement of the P5-P40 residues
of the polyprotein cleavage sequence with those of the eIF4GI site
(Fig. 8E) also did not affect the efﬁciency of Lbpro cleavage.
We next investigated the ability of sLbpro to cleave the same
ﬁve substrates. In all cases, sLbpro cleavage was delayed compared
to the Lbpro cleavage. 50% cleavage of the wild-type substrate and a
substrate bearing P1 Gly and P10 Arg occurred at 30 min (Fig. 9A
and B) compared to 15–30 min and 0–15 min, respectively, with
Lbpro (Table 1). 50% cleavage of the substrate bearing two basic
amino acids at the scissile bond was observed between 45–90 min
whereas the substrate lacking basic amino acids at the cleavage
site only showed 50% cleavage after 90 min. Finally, as was
shown previously by Cencic et al. (2007), the substrate with the
eIF4GI cleavage site was not cleaved at all, even after 120 min of
Fig. 9. Effects of P1 or P10 site mutations on the intermolecular cleavage efﬁciency of sLbpro. The intermolecular processing of the precursor Lbpro C51A VP4/VP2 (A) and
variants thereof (B–E) by sLbpro. The cleavage sequence present in the background of the polyprotein is shown in grey boxes. Differences from the wild-type sequence of the
precursor are underlined. The translation and analysis was done as shown in Fig. 8. (F) The intermolecular cleavage of endogenous eIF4GI present in the RRLs from panel E.
10 ml aliquots were analysed on a 6% Dasso & Jackson SDS-PAGE (Dasso and Jackson, 1989), followed by immunoblotting with an antiserum detecting the N-terminal part of
eIF4GI. Uncleaved eIF4GI and cleavage products (cpN) are indicated. Negative controls devoid of any RNA (sub, prot) or comprising only RNA encoding the precursor
(þsub, prot) are shown. Protein standards are shown on the left. Each cleavage reaction was performed twice; a representative autoradiogram for each is shown.
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incubation. Thus, the cleavage efﬁciencies of sLbpro on modiﬁed
polyprotein substrates are similar to those on analogously mod-
iﬁed oligopeptides, in contrast to those of Lbpro. As a control, we
examined the state of the endogenous eIF4GI present in RRLs by
performing a Western blot of the cleavage reaction using an anti-
eIF4GI antiserum (Fig. 9F). Endogenous eIF4GI was cleaved within
15 min after the start of incubation, an efﬁciency comparable to
that previously observed with Lbpro and sLbpro (Glaser et al., 2001).
This cleavage efﬁciency on endogenous eIF4GI was also observed
in all other reactions in Fig. 9 (data not shown).
How can we explain the differences observed above between
Lbpro and sLbpro in their behaviour towards oligopeptide and
polyprotein substrates (Table 2)? Why do the introduced muta-
tions only affect sLbpro cleavage and why is sLbpro not capable of
recognising the eIF4GI cleavage site in the background of the
polyprotein? The difference in the cleavage efﬁciencies between
Lbpro and sLbpro on polyprotein protein substrates can be explained
by the ability of Lbpro to bind to the cleavage site on the substrate
with its canonical substrate binding site and through its own CTE
to the “substrate binding site” of the substrate as shown in Fig. 10A
and B. In contrast, sLbpro can only make one of these interactions,
as it lacks an intact CTE (Fig. 10C and D).
sLbpro can efﬁciently cleave the eIF4GI site on the native protein
present in the RRL because this involves residues Cys133 and
Asp184-Leu188 of the CTE but not the last six residues of the CTE
(Foeger et al., 2005). Accordingly, we introduced 80 amino acids
from eIF4GI containing the Lpro binding and cleavage sites into the
Lbpro C51A VP4/VP2 substrate (Fig. 10E). This modiﬁed substrate
(termed Lbpro C51A eIF4GI599-668 VP4/VP2 SFANLGnRTTL) was
cleaved by sLbpro between 30 and 90 min, indicating that the
availability of the two binding sites had allowed cleavage to take
place (Fig. 11A).
As a control, we examined the ability of the variant sLbpro
C133S Q185R E186K that had previously been shown to be unable
to cleave endogenous eIF4GI because the variant cannot recognise
its binding site on this factor (Foeger et al., 2005). This variant
could also not cleave the Lbpro C51A eIF4GI599-668 VP4/VP2, but
maintains the ability to cleave the wild-type substrate Lbpro C51A
VP4/VP2 (Figs. 11B and C, left panels). As previously reported,
sLbpro C133S Q185R E186K was however not able to cleave
endogenous eIF4GI, even after 120 min of incubation (Figs. 11B
and C, right panels).
Concluding remarks
The structural data presented here reveal that sLbpro uses three
acidic residues to bind to basic residues at the P1 or P10 positions
Table 2
Summary of the mutational analysis of the intermolecular cleavage efﬁciency of Lbpro and sLbpro. Data are taken from Figs. 8 and 9 and Glaser et al., 2001 for cleavage of
eIF4GI by Lbpro. The experiments were performed twice.
50% cleavage (min)
pCITE Lbpro C51A VP4/VP2 endogenous eIF4GI
VQRKLKnGAGQ VQRKLGnRAGQ VQRKLKnRAGQ VQRKLGnAAGQ SFANLGnRTTL (eIF4GI) SFANLGnRTTL
Lbpro 15–30 0–15 15–30 0–15 15–30 0–15
sLbpro 30 30 45–90 90 No cleavage 0–15
Fig. 10. Model of the intermolecular cleavage of polyprotein substrates by Lbpro and sLbpro. (A and C) Cleavage of wild-type Lbpro C51A VP4/VP2 by Lbpro and sLbpro,
respectively. (B and D) Cleavage of Lbpro C51A VP4/VP2 containing the eIF4GI cleavage sequence by Lbpro and sLbpro, respectively. E. Cleavage of Lbpro C51A eIF4GI599-668 VP4/
VP2 SFANLG*RTTL by sLbpro. Lbpro is in light blue, sLbpro in dark blue, VP4 in light green, VP2 in dark green and the eIF4GI599-668 fragment in red.
J. Steinberger et al. / Virology 468-470 (2014) 397–408406
of a substrate and that this represents a unique arrangement that
is not found in cellular papain-like proteinases. Differences in the
cleavage efﬁciency of Lbpro and sLbpro were observed on modiﬁed
polyprotein substrates. The presence of sLbpro in infected cells
(Sangar et al., 1988) suggests that differences in the properties of
Lbpro and sLbpro will be relevant to the success of viral replication.
Hence, the removal of six C-terminal residues 40 Å from the active
site may represent a unique mechanism to modify the properties
of a proteolytic enzyme during viral replication.
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